Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer
Clinical trial NCT07356531 · RECRUITING
Trial details
- NCT number
- NCT07356531
- Sponsor
- JIANGSU SHENMING Medical Technology CO., Ltd
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-29
- Primary completion
- 2025-11-14
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.